Moreover, the predictive value of inflammatory markers, such as C-reactive protein (CRP) and interleukin-6 (IL-6), has been demonstrated to correlate with GDM risk, thereby underscoring the significance of systemic inflammation in its pathogenesis [11]. Here, IL6 is linked to gestational diabetes.